Cargando…
One-Year Toxicity of Ultrahypofractionated Breast Radiotherapy (+/- Sequential Boost) and a Survey of Patient Experience
PURPOSE/OBJECTIVE(S): In March 2020, a 1-week hypofractionated adjuvant breast radiotherapy schedule, 26 Gy in 5 fractions, was implemented to reduce the risk of COVID 19 virus for patients and staff without compromising on cancer outcomes. This prospective observational study aims to report late to...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595472/ http://dx.doi.org/10.1016/j.ijrobp.2022.07.694 |